• Home
  • About
    • About Panaxea
    • Meet our team
    • Careers
  • Services
    • Health Technology Assessment
    • Health Services & Systems Research
    • Health Innovation Assessment Consultancy
  • News & Cases
  • Publications
  • Contact
  • Privacy Statement Panaxea

Panaxea is proud to announce that it takes place in this consortium with 11 other parties, like the Middlesex University and Amsterdam’s Emma Children’s Hospital. CRADL (which stands for Continuous Regional Analysis Device for neonate Lung) will show how EID can provide new cost effective, easy to use, respiratory management tools and clinical protocols to reduce deaths and disability in infants and children with respiratory failure.

Take a look on the project website for more information about the goals of CRADL, or to see the other participating parties.

Panaxea b.v. supports decision making in healthcare by assessing the relative advantage of healthcare innovations. Our clients include patients, health and life science innovators and investors, health technology adopters, public and private payers, and policymakers.

Follow us on Twitter

Tweets by @PANAXEA

Useful Links

Home
About Panaxea
Services
Publications
Contact Us

Social Media

 Twitter Linkedin

Contact Information

PANAXEA b.v.
Pettelaarpark 84
5216 PP Den Bosch
The Netherlands

+31 20 7400 778
www.panaxea.eu
info@panaxea.eu

© 2019 Panaxea. All Rights Reserved.
  • Privacy Statement Panaxea
  • No translations available for this page